- Report
- March 2024
- 190 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- February 2024
- 112 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Drug Pipelines
- July 2022
- 100 Pages
Global
From €2654EUR$2,750USD£2,277GBP
The Combined Oral Contraceptive Pill (COCP) is a form of hormonal contraception used by women to prevent pregnancy. It is taken orally and contains two hormones, estrogen and progestin, which work together to stop ovulation and thicken the cervical mucus, making it difficult for sperm to reach the egg. The COCP is a safe and effective form of contraception, with a failure rate of less than 1%. It also has other benefits, such as reducing the risk of ovarian and endometrial cancer, and helping to regulate menstrual cycles.
The COCP market is an important part of Women's Health, providing women with a reliable and convenient form of contraception. It is widely available, with many different brands and formulations available.
Some companies in the COCP market include Bayer, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more